CN1056759C - Traditional Chinese medicine preparation for prevention and treatment of hepatitis B - Google Patents

Traditional Chinese medicine preparation for prevention and treatment of hepatitis B Download PDF

Info

Publication number
CN1056759C
CN1056759C CN95103883A CN95103883A CN1056759C CN 1056759 C CN1056759 C CN 1056759C CN 95103883 A CN95103883 A CN 95103883A CN 95103883 A CN95103883 A CN 95103883A CN 1056759 C CN1056759 C CN 1056759C
Authority
CN
China
Prior art keywords
gram
hepatitis
medicinal liquid
add
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN95103883A
Other languages
Chinese (zh)
Other versions
CN1112018A (en
Inventor
张立中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN95103883A priority Critical patent/CN1056759C/en
Publication of CN1112018A publication Critical patent/CN1112018A/en
Application granted granted Critical
Publication of CN1056759C publication Critical patent/CN1056759C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses medicament for preventing and treating hepatitis B, which is in the form of tea, instant granules, oral liquid, etc. which is prepared from astragalus root, Chinese angelica root, wolfberry fruit, giant knotweed rhizome, China root, honeycomb, Chinese caterpillar fungus, glossy privet fruit, cimicifuga root and liquoric root.

Description

The Chinese medicine preparation of a kind of prevention and treatment hepatitis B
The present invention is the Chinese medicine of a kind of prevention and treatment hepatitis B and hepatitis B virus carriers.Specifically, relating to the Chinese herbal medicine is the Chinese drugs agentia with prevention and treatment hepatitis B and hepatitis B virus carriers that raw material is made, and comprises medicinal tea, electuary, oral liquid etc.
There are 1.2 hundred million people to carry hepatitis B virus approximately in China, 1,500 ten thousand chronic hepatitis B patients are arranged approximately.In a single day people infect hepatitis B virus, must carry out the practice of each person having an individual portion of food, and active treatment.No matter be hepatitis B virus carriers, or hepatitis B patient, the healthy of people all seriously endangered.The person of being in a bad way develops into liver cirrhosis, and part patient finally develops into hepatocarcinoma, jeopardizes people's life.The medical personnel of countries in the world is endeavouring to study the medicine of seeking the treatment hepatitis B, up to the present also do not treat the specific medicament of hepatitis B, therefore, the method of taking in treatment and the medicine of use have nothing in common with each other, generally all be symptomatic treatment, adopt and protect the liver, fall enzyme, press down measures such as poison.Commonly usedly clinically at present fall enzyme medicine Fructus Schisandrae Chinensis preparation and bifendate, though the transaminase lowering effect is very fast, the knock-on rate is up to more than 60%, and, jaundice turbid to Moschus moschiferous and Australia antigen are turned out cloudy and do not had obviously effect; Hepatic glucuronolatone commonly used, coenzyme A, inosine etc. and anti-hepatitis virus medicament interferon etc. can make the part patient, and HBsAg, HBeAg turn out cloudy or titre descends, in case but drug withdrawal, easily knock-on is multiple rises, and can not suppress hepatitis B virus enduringly.Thereby make the hepatitis B patient long-term prescription of having to.Factors such as drug treatment is grown, cost an arm and a leg, medicine-feeding way inconvenience make vast loyal person be difficult to accept whole-course treatment.Sb.'s illness took a turn for the worse because of affecting treatment adversely to cause most patients.Seek a kind of effectively and the medicine of taking convenience to be most of hepatitis B patient press for.CN1083712A discloses a kind of medicine of preventing and treating hepatitis B, and this medicine is made up of nine flavor Chinese medicines such as the Radix Astragali, Radix Pseudostellariae, Fructus Lycii, Radix Bupleuri, the Radix Paeoniae Alba, Radix Salviae Miltiorrhizae, Rhizoma Polygoni Cuspidati, Herba Hedyotidis Diffusae, Radix Et Rhizoma Rhei, and has reached certain therapeutic effect.CN1085446A discloses a kind of hepatitis B virus converting negative tablet, and this medicine is that Rhizoma Coptidis, Rhizoma Polygoni Cuspidati, Cordyceps, Radix Glycyrrhizae are mixed by a certain percentage, makes tablet through cleaning, dry, pulverizing.Although above-mentioned two kinds of Chinese medicines have certain inhibitory action for hepatitis B virus, and obtained curative effect preferably, but owing to contain bitter cold antidote Radix Et Rhizoma Rhei, Rhizoma Coptidis in above-mentioned two kinds of medicines, and most of hepatitis B patient shows as insufficiency of the spleen symptom, take the bitter cold medicine can damage in burnt yang-energy, increase the weight of the insufficiency of the spleen state of an illness, thereby for insufficiency of the spleen hepatitis B patient, be not suitable for taking above-mentioned two kinds of medicines.The inventor cooperates patient's needs through long-term clinical observation, has developed a kind of taking convenience and the Chinese medicine medicinal tea of respond well treatment hepatitis B.
Therefore, the object of the invention provides a kind of active drug for the treatment of hepatitis B and hepatitis B virus carriers.
Another object of the present invention provides a kind of taking convenience and the Chinese medicine medicinal tea of the treatment hepatitis B accepted by hepatitis B patient easily.
Medicine of the present invention is to be made by the Radix Astragali, Radix Angelicae Sinensis, Fructus Lycii, Rhizoma Polygoni Cuspidati, Rhizoma Smilacis Glabrae, Nidus Vespae, Cordyceps, RHIIZOMA CIMICIFUGAE, Fructus Ligustri Lucidi, Radix Glycyrrhizae.
Pharmaceutical compositions compositing range of the present invention is:
Radix Astragali 10-15 gram Radix Angelicae Sinensis 5-10 gram Fructus Lycii 5-10 gram
Rhizoma Polygoni Cuspidati 10-15 gram Rhizoma Smilacis Glabrae 8-12 gram Nidus Vespae 4-8 gram
Cordyceps 4-10 gram RHIIZOMA CIMICIFUGAE 3-5 gram Fructus Ligustri Lucidi 5-10 gram
Radix Glycyrrhizae 5-10 gram
The preferred weight proportioning of pharmaceutical formulation each component of the present invention is:
The Radix Astragali 15%, Radix Angelicae Sinensis 10%, Fructus Lycii 10%, Rhizoma Polygoni Cuspidati 15%, Rhizoma Smilacis Glabrae 10%,
Nidus Vespae 5%, Cordyceps 10%, RHIIZOMA CIMICIFUGAE 5%, Fructus Ligustri Lucidi 10%, Radix Glycyrrhizae 10%
The processing technique of medicine medicinal tea of the present invention is:
The said herbal medicine crude drug of formula ratio is chosen decontamination, mix, dry, pulverize, sieve, in the sterilising filtration tea bag of packing into, seal promptly, have the short-term that leads drawings on the tea bag.
Medicine of the present invention can also be made conventional pharmaceutical dosage form except being made into above-mentioned medicinal tea place, as electuary, and oral liquid, tablet, capsule etc.
The preparation technology of medicine instant of the present invention is:
By above-mentioned formula ratio, the herbal raw material medicine is chosen decontamination, mixed powder is broken into coarse powder (5-10 order), put into extraction pot, the water that adds 3 times of amounts of crude drug weight boils back slow fire and boiled one hour again, leaches medicinal liquid, and then the water of adding Chinese herbal medicine weight qdx, boil back slow fire and boil half an hour again, leach medicinal liquid, front and back secondary medicinal liquid is merged, the cooling back adds 1-2 and doubly measures fully mixing placement of ethanol (concentration 90%), precipitation.Get its supernatant after 20 hours, precipitate is cleaned with a small amount of 50-60% ethanol, washing liquid and filtrate merge, decompression recycling ethanol, after being concentrated to finite concentration, cooling was left standstill 12 hours again, made thorough precipitation, filtration, the filtrate low-temperature evaporation is standby to the thick paste shape, and the ratio of thick paste is reheated survey (80-90 ℃) for 1.30-1.35.Wear into fine powder with crystallization of sucrose, it is standby to cross the 80-100 mesh sieve, and it is standby to get commercially available dextrin, and Chinese herb medicine thick paste, Icing Sugar, dextrin are got finished product by 1: 3: 1 weight ratio stirring and evenly mixing.
The preparation technology of oral liquid of the present invention is:
According to preparation identical prepared Chinese herbal medicine thick paste during electuary, with an amount of distilled water diluting of thick paste, filter, it is 20% that diluent contains the crude drug amount, add simple syrup, Pyrusussuriensis potassium alcoholate (content should be up to specification by 90 years version pharmacopeia) sterilization, be packaged in 10ml oral liquid ampoule (up to specification), make the oral liquid finished product by requirement under 90 years version oral liquid items.
Medicine of the present invention has function of resisting hepatitis B virus, can improve immune function, and preventing cold is arranged, and increases the effect of appetite.Take medicated tea observation of the present invention through 120 routine hepatitis patients or hepatitis B virus carriers, effective percentage 98%, antigen of hepatitis B virus negative conversion rate HBsAg33.7%, HBeAg48.8% generally was one with three months and takes medicine the course of treatment that the elder can reach 1 year.
Model case
Example 1: man 32 years old, chronic persistent hepatitis.Suffered from hepatitis B 6 years, the recurrence in every year, ALT often fluctuation often catches a cold inappetence about 100U.HBsAg, HBeAg are all positive, and through obeying this tea nearly 3 years, two antigens are all turned out cloudy, and two and half do not catch a cold.Household's secondary flu before and after New Year's Day in 1994, only this patient escapes by luck.The more preceding remarkable increase of appetite.Liver function 2 years is normal.
Example 2: woman 26 years old, chronic persistent hepatitis SGPT fluctuates between 300-400U, and HBsAg, HBeAg are all positive.Hospitalization two months is not more left hospital because of economic cause.Consider inexpensive and take this tea.Drinking tea through 2 years, two antigens are all cloudy to be changeed.The now anti-HBc positive, liver function a year and a half normal, two antigens are cloudy to be changeed more than 1 year.Do not catch a cold behind the clothes tea, the more preceding increase of appetite, energy is more preceding abundant.
Embodiment:
Get 15 kilograms of 10 kilograms of Rhizoma Polygoni Cuspidati of 10 kilograms of Fructus Lycii of 15 kilograms of Radix Angelicae Sinensis of the Radix Astragali,
5 kilograms of 10 kilograms of RHIIZOMA CIMICIFUGAEs of 5 kilograms of Cordyceps of 10 kilograms of Nidus Vespae of Rhizoma Smilacis Glabrae
10 kilograms in 10 kilograms of Radix Glycyrrhizaes of Fructus Ligustri Lucidi
The above-mentioned raw materials medicine is chosen decontamination, and oven dry is pulverized, and sieves, and packs into to go out in the filtration tea bag of castor, makes 100 kilograms of teabag finished products.

Claims (6)

  1. One kind the prevention and the treatment hepatitis B Chinese medicine preparation, it is characterized in that said composition is to be made by the following raw material medicaments thing:
    Radix Astragali 10-15 gram Radix Angelicae Sinensis 5-10 gram Fructus Lycii 5-10 gram
    Rhizoma Polygoni Cuspidati 10-15 gram Rhizoma Smilacis Glabrae 8-12 gram Nidus Vespae 4-8 gram
    Cordyceps 4-10 gram RHIIZOMA CIMICIFUGAE 3-5 gram Fructus Ligustri Lucidi 5-10 gram
    Radix Glycyrrhizae 5-10 gram.
  2. 2. medicament according to claim 1 is characterized in that the percentage by weight of each component is:
    The Radix Astragali 15%, Radix Angelicae Sinensis 10%, Fructus Lycii 10%, Rhizoma Polygoni Cuspidati 15%, Rhizoma Smilacis Glabrae 10%, Nidus Vespae 5%, Cordyceps 10%, RHIIZOMA CIMICIFUGAE 5%, Fructus Ligustri Lucidi 10%, Radix Glycyrrhizae 10%.
  3. 3. medicament according to claim 1 and 2 is characterized in that it is medicinal tea or electuary or oral liquid formulation.
  4. 4. the preparation method of the described medicament electuary of claim 3 is characterized in that the crude drug of formula ratio is pulverized, decocted with water, and the gained medicinal liquid is condensed into thick paste, adds Icing Sugar, dextrin, and mixing makes finished product.
  5. 5. preparation method according to claim 4 is characterized in that the Chinese herbal medicine dry product of formula ratio is ground into coarse powder, add the water boil one hour of crude drug weight triplication, go out medicinal liquid, add qdx water boil half an hour again, go out medicinal liquid, the secondary medicinal liquid merges, and the cooling back adds 1-2 and doubly measures the ethanol mixing, place post precipitation and get supernatant, reclaim ethanol, concentrated supernatant, leave standstill, filter, flash to paste, with thick paste, Icing Sugar, dextrin ratio mixing, make finished product in 1: 3: 1.
  6. 6. the preparation method of the described oral liquid of claim 3 is characterized in that the Chinese herbal medicine dry product of formula ratio is ground into coarse powder, add the water boil one hour of crude drug weight triplication, go out medicinal liquid, add qdx water boil half an hour again, go out medicinal liquid, the secondary medicinal liquid merges, and the cooling back adds 1-2 and doubly measures the ethanol mixing, places post precipitation and gets supernatant, reclaim ethanol, concentrated supernatant leaves standstill, and filters, flash to paste, add distilled water diluting, make diluent contain crude drug amount 20%, add simple syrup again, the Pyrusussuriensis potassium alcoholate, dosage by 90 years version pharmacopeia regulations, filter sterilization, encapsulation.
CN95103883A 1995-04-24 1995-04-24 Traditional Chinese medicine preparation for prevention and treatment of hepatitis B Expired - Fee Related CN1056759C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN95103883A CN1056759C (en) 1995-04-24 1995-04-24 Traditional Chinese medicine preparation for prevention and treatment of hepatitis B

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN95103883A CN1056759C (en) 1995-04-24 1995-04-24 Traditional Chinese medicine preparation for prevention and treatment of hepatitis B

Publications (2)

Publication Number Publication Date
CN1112018A CN1112018A (en) 1995-11-22
CN1056759C true CN1056759C (en) 2000-09-27

Family

ID=5074900

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95103883A Expired - Fee Related CN1056759C (en) 1995-04-24 1995-04-24 Traditional Chinese medicine preparation for prevention and treatment of hepatitis B

Country Status (1)

Country Link
CN (1) CN1056759C (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1056423A (en) * 1990-05-11 1991-11-27 陈江辉 Qingganbao oral liquid compounding method
CN1066785A (en) * 1992-04-21 1992-12-09 沈阳中药厂 The preparation method of Yinshanlian electuary
CN1097129A (en) * 1993-07-05 1995-01-11 万传贵 Multiple effect liver-protecting medicine and compound method

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1056423A (en) * 1990-05-11 1991-11-27 陈江辉 Qingganbao oral liquid compounding method
CN1066785A (en) * 1992-04-21 1992-12-09 沈阳中药厂 The preparation method of Yinshanlian electuary
CN1097129A (en) * 1993-07-05 1995-01-11 万传贵 Multiple effect liver-protecting medicine and compound method

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
《吉林中医药》(4) 1983.4.30 蒋森,慢性乙型肝炎中医治疗初探 *
《吉林中医药》(4) 1983.4.30 蒋森,慢性乙型肝炎中医治疗初探;《四川医药》10(2) 1992.2.29 赵承宣,益气调肝汤为主治疗乙肝;《四川医药》5(3) 1987.3.31 李玉银,乙肝煎治疗乙型肝炎25例 *
《四川医药》10(2) 1992.2.29 赵承宣,益气调肝汤为主治疗乙肝 *
《四川医药》5(3) 1987.3.31 李玉银,乙肝煎治疗乙型肝炎25例 *

Also Published As

Publication number Publication date
CN1112018A (en) 1995-11-22

Similar Documents

Publication Publication Date Title
CN102335379A (en) Traditional Chinese preparation for relieving alcoholism and protecting livers
CN102335335A (en) Traditional Chinese medicine preparation with effects of health care and physical fatigue alleviation
CN104083727A (en) Traditional Chinese medicine composition for nourishing and protecting liver
CN1245707A (en) Chinese medicine for curing AIDS and carcinomatosis
US9789153B2 (en) Composition for preventing cancer and treating cancer and intensifying the effects of other anticancer drugs
CN105535448A (en) Traditional Chinese medicine composition for treating child myasthenia gravis
CN1145240A (en) Medicinal compsn. for prevention of Aids virus and cancer
CN1689613A (en) Prescription and preparation of product for preventing and treating wind-heat type cold and virus infected cold
CN102846879B (en) Composition for depressing blood fat
CN1243743A (en) Medicine for treating chronic hepatism and its preparing process
CN1054515C (en) Medicine for prevention and cure of hepatitis B
CN102008598B (en) Blood fat-lowering and liver-protecting composite as well as preparation prepared thereby and preparation method of preparation
CN1059556C (en) Compound bufonin of bufo gargarizans
CN1056759C (en) Traditional Chinese medicine preparation for prevention and treatment of hepatitis B
CN101011470B (en) Traditional Chinese medicine compound composition for treating hepatitis
CN1730090A (en) Chinese traditional medicinal composition for treating hepatitis and process for preparing the same
CN1814250B (en) Chinese medicine composition for treating liver cirrhosis ascites and preparation method thereof
CN88100048A (en) The production method of Chinese patent medicine AIDS spirit (AIDSLIUM) preparation
CN101385783A (en) Huganning tablets for treating chronic and urgent liver disease and preparation method thereof
CN1830482B (en) Chinese medicinal composition and application for treating child pneumonia for treating
CN112914009A (en) Health-care solid beverage for yang-deficiency constitution and preparation method thereof
CN105641168A (en) Medicine for treating viral hepatitis B and viral hepatitis C and preparation method of medicine
CN1086129C (en) Hepatitis restoration pill
CN1059783C (en) Refreshing and mellow liver nourishing tea
CN1171257A (en) Chinese-herbal medicine for curing hepatitis B and its preparing process

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee